Inhibiting The Androgen Receptor - Cancer Science

Relevant Publications

Schisandrin B alleviates testicular inflammation and Sertoli cell apoptosis via AR-JNK pathway.

Issue Release: 2024

Androgen receptor activity inversely correlates with immune cell infiltration and immunotherapy response across multiple cancer lineages.

Issue Release: 2024

JMJD2A promotes the development of castration-resistant prostate cancer by activating androgen receptor enhancer and inhibiting the cGAS-STING pathway.

Issue Release: 2024

Obacunone improves dihydrotestosterone-induced androgen alopecia by inhibiting androgen receptor dimerization.

Issue Release: 2024

QSAR, molecular docking, and pharmacokinetic analysis of thiosemicarbazone-indole compounds targeting prostate cancer cells.

Issue Release: 2024

18β-Glycyrrhetinic acid synergizes with enzalutamide to counteract castration-resistant prostate cancer by inhibiting OATP2B1 uptake of dehydroepiandrosterone.

Issue Release: 2024

ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer.

Issue Release: 2024

Sex-specific outcomes in cancer therapy: the central role of hormones.

Issue Release: 2024

Activation of testosterone-androgen receptor mediates cerebrovascular protection by photobiomodulation treatment in photothrombosis-induced stroke rats.

Issue Release: 2024

Butorphanol inhibits androgen biosynthesis and metabolism in rat immature Leydig cells in vitro.

Issue Release: 2024

Agent-based modeling of the prostate tumor microenvironment uncovers spatial tumor growth constraints and immunomodulatory properties.

Issue Release: 2024

From gains to gaps? How Selective Androgen Receptor Modulator (SARM) YK11 impact hippocampal function: In silico, in vivo, and ex vivo perspectives.

Issue Release: 2024

SC912 inhibits AR-V7 activity in castration-resistant prostate cancer by targeting the androgen receptor N-terminal domain.

Issue Release: 2024

Aberrant activated Notch1 promotes prostate enlargement driven by androgen signaling via disrupting mitochondrial function in mouse.

Issue Release: 2024

ID2 Promotes Lineage Transition of Prostate Cancer through FGFR and JAK-STAT Signaling.

Issue Release: 2024

Effects of Camellia oleifera seed shell polyphenols and 1,3,6-tri-O-galloylglucose on androgenic alopecia via inhibiting 5a-reductase and regulating Wnt/β-catenin pathway.

Issue Release: 2024

Interaction of Bisphenol A and Its Analogs with Estrogen and Androgen Receptor from Atlantic Cod ().

Issue Release: 2024

New insights into prostate Cancer from the renin-angiotensin-aldosterone system.

Issue Release: 2024

Inflammation impacts androgen receptor signaling in basal prostate stem cells through interleukin 1 receptor antagonist.

Issue Release: 2024

Potential antiandrogenic effects of parabens and benzophenone-type UV-filters by inhibition of 3α-hydroxysteroid dehydrogenases.

Issue Release: 2024

What Is the Future of Targeted Prevention Strategies?

Are There Any Approved Oligonucleotide Therapies for Cancer?

Does sadness affect the prognosis of cancer?

Do Fibroadenomas Increase the Risk of Breast Cancer?

Why Consider Cancer-Specific Insurance?

Can Blister Packs Improve Medication Adherence in Cancer Patients?

How Can One Volunteer or Support the Program?

How can healthcare systems improve patient involvement?

How is Genomics Data Collected?

What is Open Science?

Partnered Content Networks

Relevant Topics